432
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Trends in mental health and substance use disorders and treatment receipt among pregnant and nonpregnant women in the United States, 2008–2014

, , ORCID Icon, & ORCID Icon
Pages 298-307 | Received 07 Jul 2018, Accepted 01 Nov 2019, Published online: 13 Nov 2019

References

  • Cook CA, Flick LH, Homan SM, et al. Psychiatric disorders and treatment in low-income pregnant women. J Womens Health. 2010;19(7):1251–1262.
  • Ko JY, Farr SL, Dietz PM, et al. Depression and treatment among US pregnant and nonpregnant women of reproductive age, 2005–2009. J Womens Health. 2012;21(8):830–836.
  • Le Strat Y, Dubertret C, Le Foll B. Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States. J Affect Disord. 2011;135(1–3):128–138.
  • Mota N, Cox BJ, Enns MW, et al. The relationship between mental disorders, quality of life, and pregnancy: findings from a nationally representative sample. J Affect Disord. 2008;109(3):300–304.
  • Vesga-Lopez O, Blanco C, Keyes K, et al. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry. 2008;65(7):805–815.
  • Connelly CD, Hazen AL, Baker-Ericzen MJ, et al. Is screening for depression in the perinatal period enough? The co-occurrence of depression, substance abuse, and intimate partner violence in culturally diverse pregnant women. J Womens Health. 2013;22(10):844–852.
  • Grigoriadis S, VonderPorten EH, Mamisashvili L. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry. 2013;74(04):e321–e341.
  • Goodman JH, Chenausky KL, Freeman MP. Anxiety disorders during pregnancy: a systematic review. J Clin Psychiatry. 2014;75(10):e1153–e1184.
  • Norhayati M, Hazlina NN, Asrenee A, et al. Magnitude and risk factors for postpartum symptoms: a literature review. J Affect Disord. 2015;175:34–52.
  • Lehikoinen A, Orden MR, Heinonen S, et al. Maternal drug or alcohol abuse is associated with decreased head size from mid-pregnancy to childhood. Acta Paediatr. 2016;105(7):817–822.
  • Narkowicz S, Płotka J, Polkowska Ż, et al. Prenatal exposure to substance of abuse: a worldwide problem. Environ Int. 2013;54:141–163.
  • Ondersma SJ, Simpson SM, Brestan EV, et al. Prenatal drug exposure and social policy: the search for an appropriate response. Child Maltreat. 2000;5(2):93–108.
  • Patrick SW, Davis MM, Lehmann CU, et al. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015;35(8):650–655.
  • American College of Obstetricians and Gynecologists. Committee opinion no. 633: Alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice. Obstet Gynecol. 2015;125(6):1529–1537.
  • American College of Obstetricians and Gynecologists. Screening for perinatal depression; 2015. [cited 2017 Jun 20]. Available from: https://www.acog.org/-/media/Committee-Opinions/Committee-on-Obstetric-ractice/co630.pdf?dmc=1&ts=20160630T152101795
  • Glasheen C, Colpe L, Hoffman V, et al. Prevalence of serious psychological distress and mental health treatment in a national sample of pregnant and postpartum women. Matern Child Health J. 2015;19(1):204–216.
  • United States Department of Health and Human Services. 2009. Actions steps for improving women’s mental health. [cited 2017 Jun 20]. Available from: https://store.samhsa.gov/shin/content/OWH09-PROFESSIONAL/OWH09-PROFESSIONAL.pdf
  • Center for Substance Abuse Treatment. Substance abuse treatment: addressing the specific needs of women. 2009 [cited 2017 May 15]. Available from: http://store.samhsa.gov/shin/content//SMA15-4426/SMA15-4426.pdf
  • Mental Health Parity and Addiction Equity Act, Pub. L. No. 110-343, 122 Stat. 3765, H.R. 1424, 110th Cong. [cited 2017 May 22]. Available from: https://www.cms.gov/CCIIO/Programs-and-Initiatives/Other-Insurance-Protections/mhpaea_factsheet.html#Key changes made by MHPAEA.
  • Patient Protection and Affordable Care Act, 42 U.S.C. § 1800. [cited 2017 May 22]. Available from: https://www.gpo.gov/fdsys/pkg/PLAW-111publ148/html/PLAW-111publ148.htm
  • Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 2005;352(24):2515–2523.
  • Mojtabai R, Jorm AF. Trends in psychological distress, depressive episodes and mental health treatment-seeking in the United States: 2001-2012. J Affect Disord. 2015;174:556–561.
  • Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008;198(2):194. e191–194. e195.
  • Bobo WV, Epstein RA, Hayes RM, et al. The effect of regulatory advisories on maternal antidepressant prescribing, 1995–2007: an interrupted time series study of 228,876 pregnancies. Arch Womens Ment Health. 2014;17(1):17–26.
  • Meunier MR, Bennett IM, Coco AS. Use of antidepressant medication in the United States during pregnancy, 2002–2010. Psychiatr Serv. 2013;64(11):1157–1160.
  • McCabe JE, Arndt S. Demographic and substance abuse trends among pregnant and non-pregnant women: eleven years of treatment admission data. Matern Child Health J. 2012;16(8):1696–1702.
  • Pan I-J, Yi H-y. Prevalence of hospitalized live births affected by alcohol and drugs and parturient women diagnosed with substance abuse at liveborn delivery: United States, 1999–2008. Matern Child Health J. 2013;17(4):667–676.
  • Maeda A, Bateman BT, Clancy CR, et al. Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology. 2014;121(6):1158–1165.
  • Martin CE, Longinaker N, Terplan M. Recent trends in treatment admissions for prescription opioid abuse during pregnancy. J Subst Abuse Treat. 2015;48(1):37–42.
  • Martin CE, Longinaker N, Mark K, et al. Recent trends in treatment admissions for marijuana use during pregnancy. J Addict Med. 2015;9(2):99–104.
  • Center for Behavioral Health Statistics and Quality. 2014 National Survey on Drug Use and Health: methodological summary and definitions. Rockville (MD); 2015.
  • United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. 2012 National Survey on Drug Use and Health: Public use file codebook. Rockville (MD); 2013.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM IV. Washington (DC): American Psychiatric Association; 1994.
  • Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60(2):184–189.
  • Endicott J, Spitzer RL, Fleiss JL, et al. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33(6):766–771.
  • Thoemmes F. Propensity Score Matching in SPSS [Computer software]; 2012. Avialable from: https://arxiv.org/abs/1201.6385
  • Fairbrother N, Janssen P, Antony MM, et al. Perinatal anxiety disorder prevalence and incidence. J Affect Disord. 2016;200:148–155.
  • Battle CL, Salisbury AL, Schofield CA, et al. Perinatal antidepressant use: understanding women’s preferences and concerns. J Psychiatr Pract. 2013;19(6):443.
  • Kim JJ, La Porte LM, Corcoran M, et al. Barriers to mental health treatment among obstetric patients at risk for depression. Am J Obstet Gynecol. 2010;202(3):312–3e1.
  • Byatt N, Simas TAM, Lundquist RS, et al. Strategies for improving perinatal depression treatment in North American outpatient obstetric settings. J Psychosom Obstet Gynaecol. 2012;33(4):143–161.
  • American College of Obstetricians and Gynecologists. Committee opinion no. 453: Screening for depression during and after pregnancy. Obstet Gynecol. 2010;115(2):394.
  • Leddy MA, Lawrence H, Schulkin J. Obstetrician-gynecologists and women's mental health: findings of the Collaborative Ambulatory Research Network 2005–2009. Obstet Gynecol Surv. 2011;66(5):316–323.
  • Byatt N, Biebel K, Debordes-Jackson G, et al. Community mental health provider reluctance to provide pharmacotherapy may be a barrier to addressing perinatal depression: a preliminary study. Psychiatr Q. 2013;84(2):169–174.
  • Palladino CL, Fedock GL, Forman JH, et al. OB CARES – The Obstetric Clinics and Resources Study: providers' perceptions of addressing perinatal depression – a qualitative study. Gen Hosp Psychiatry. 2011;33(3):267–278.
  • Price SK, Corder-Mabe J, Austin K. Perinatal depression screening and intervention: enhancing health provider involvement. J Womens Health. 2012;21(4):447–455.
  • Kopelman RC, Moel J, Mertens C, et al. Barriers to care for antenatal depression. Psychiatr Serv. 2008;59(4):429–432.
  • Jesse DE, Dolbier CL, Blanchard A. Barriers to seeking help and treatment suggestions for prenatal depressive symptoms: Focus groups with rural low-income women. Issues Ment Health Nurs. 2008;29(1):3–19.
  • Substance Abuse and Mental Health Services Administration. Trends in substances of abuse among pregnant women and women of childbearing age in treatment. 2013. [cited 2017 May 15]. Available from: http://www.samhsa.gov/data/sites/default/files/spot110-trends-pregnant-women-2013.pdf
  • Persson A, Back SE, Killeen TK, et al. Concurrent treatment of PTSD and substance use disorders using prolonged exposure (COPE): A pilot study in alcohol-dependent women. J Addict Med. 2017;11(2):119.
  • Resko SM, Kruman Mountain S, Browne S, et al. Suicidal ideation and suicide attempts among women seeking treatment for substance use and trauma symptoms. Health Soc Work. 2018;43(2):76–83.
  • Benningfield MM, Dietrich MS, Jones HE, et al. Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes. Addiction. 2012;107:74–82.
  • Holbrook A, Kaltenbach K. Co-occurring psychiatric symptoms in opioid-dependent women: the prevalence of antenatal and postnatal depression. Am J Drug Alcohol Abuse. 2012;38(6):575–579.
  • Lipsky S, Krupski A, Roy-Byrne P, et al. Effect of co-occurring disorders and intimate partner violence on substance abuse treatment outcomes. J Subst Abuse Treat. 2010;38(3):231–244.
  • Otiashvili D, Kirtadze I, O’Grady KE, et al. Access to treatment for substance-using women in the Republic of Georgia: socio-cultural and structural barriers. Int J Drug Policy. 2013;24(6):566–572.
  • Tuchman E. Women and addiction: the importance of gender issues in substance abuse research. J Addict Dis. 2010;29(2):127–138.
  • Substance Abuse and Mental Health Services Administration. 2014. SAMHSA’s concept of trauma and guidance for a trauma-informed approach. [cited 2017 May 15]. Available from: http://store.samhsa.gov/shin/content/SMA14-4884/SMA14-4884.pdf
  • Upshur CC, Jenkins D, Weinreb L, et al. Prevalence and predictors of substance use disorders among homeless women seeking primary care: An 11 site survey. Am J Addict. 2017;26(7):680–688.
  • Hamilton BE, Martin JA, Osterman MJ, et al. Births: final data for 2014. National vital statistics reports. [cited 2019 August 20]. Available from: https://www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_12.pdf

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.